(Q38312047)

2 September 2017

title

Evidence that de novo protein synthesis is dispensable for anti-apoptotic effects of NF-kappaB. (English)

1 reference

2 September 2017

0 references

0 references

S Kajino

1

1 reference

2 September 2017

M Suganuma

2

1 reference

2 September 2017

F Teranishi

3

1 reference

2 September 2017

N Takahashi

4

1 reference

2 September 2017

T Tetsuka

5

1 reference

2 September 2017

H Ohara

6

1 reference

2 September 2017

M Itoh

7

1 reference

2 September 2017

T Okamoto

8

1 reference

2 September 2017

language of work or name

English

0 references

publication date

1 April 2000

1 reference

2 September 2017

1 reference

2 September 2017

volume

19

1 reference

2 September 2017

issue

18

1 reference

2 September 2017

page(s)

2233-2239

1 reference

https://scigraph.springernature.com/pub.10.1038/sj.onc.1203560

2 September 2017

exact match

0 references

cites work

Embryonic lethality and liver degeneration in mice lacking the RelA component of NF-κB

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203560

An essential role for NF-kappaB in preventing TNF-alpha-induced cell death

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203560

The NF-kappa B and I kappa B proteins: new discoveries and insights

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203560

Coupling of a signal response domain in I kappa B alpha to multiple pathways for NF-kappa B activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203560

Suppression of tumor necrosis factor-induced cell death by inhibitor of apoptosis c-IAP2 is under NF-kappaB control

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203560

Inhibition of NF-kappa B by sodium salicylate and aspirin

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203560

Molecular mechanisms of constitutive NF-kappaB/Rel activation in Hodgkin/Reed-Sternberg cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203560

Dissection of TNF receptor 1 effector functions: JNK activation is not linked to apoptosis while NF-kappaB activation prevents cell death

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203560

Aberrant overexpression of 53BP2 mRNA in lung cancer cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203560

In vivo transfection of cis element "decoy" against nuclear factor-kappaB binding site prevents myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203560

A rapid and simple method for measuring thymocyte apoptosis by propidium iodide staining and flow cytometry

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203560

Double identity for proteins of the Bcl-2 family

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203560

Antioxidants modulate acute solar ultraviolet radiation-induced NF-kappa-B activation in a human keratinocyte cell line

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203560

Inhibition of human immunodeficiency virus type 1 replication by a bioavailable serine/threonine kinase inhibitor, fasudil hydrochloride

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203560

Okadaic acid: an additional non-phorbol-12-tetradecanoate-13-acetate-type tumor promoter

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203560

Apoptosis in the pathogenesis and treatment of disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203560

Anti-rheumatic compound aurothioglucose inhibits tumor necrosis factor-alpha-induced HIV-1 replication in latently infected OM10.1 and Ach2 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203560

Suppression of TNF-alpha-induced apoptosis by NF-kappaB

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203560

Expression of the neoplastic phenotype by human thyroid carcinoma cell lines requires NFkappaB p65 protein expression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203560

TNF- and cancer therapy-induced apoptosis: potentiation by inhibition of NF-kappaB

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203560

NF-kappaB antiapoptosis: induction of TRAF1 and TRAF2 and c-IAP1 and c-IAP2 to suppress caspase-8 activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203560

IEX-1L, an apoptosis inhibitor involved in NF-kappaB-mediated cell survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203560

NF-kappaB subunit p65 binds to 53BP2 and inhibits cell death induced by 53BP2

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203560

IkappaB-NF-kappaB structures: at the interface of inflammation control

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203560

7 January 2021

How the glucocorticoids suppress immunity

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203560

7 January 2021

Regulation of NF-kappa B and disease control: identification of a novel serine kinase and thioredoxin as effectors for signal transduction pathway for NF-kappa B activation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203560

7 January 2021

Induction of cytokines and ICAM-1 by proinflammatory cytokines in primary rheumatoid synovial fibroblasts and inhibition by N-acetyl-L-cysteine and aspirin

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203560

7 January 2021

Control of inducible chemoresistance: enhanced anti-tumor therapy through increased apoptosis by inhibition of NF-kappaB

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203560

7 January 2021

Inhibition of IL-6 and IL-8 induction from cultured rheumatoid synovial fibroblasts by treatment with aurothioglucose

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203560

7 January 2021

Identifiers

DOI

10.1038/SJ.ONC.1203560

1 reference

Dimensions Publication ID

2 September 2017

1012353120

0 references

1 reference